is inhibited by inhibitor of nuclear factor kappa B (IκB). Activation of IκB kinase (IKK) leads to IκB degradation, freeing NF-κB to enter the nucleus and induce gene transcription to stimulate an inflammatory response. Inhibition of NF-κB in osteoblast lineage cells reduces bone resorption and enhances coupled bone formation to reduce periodontal bone loss (Pacios et al. 2015) .
Periodontal ligament (PDL) fibroblasts may participate in periodontal inflammation by releasing cytokines and chemokines (Garlet et al. 2008; Jönsson et al. 2009; Zhang et al. 2016) . PDL cells are fibroblast-like cells but also exhibit some osteoblastic features. A small portion of PDL cells show high expressions of alkaline phosphatase and bone-associated proteins (Somerman et al. 1990; Giannopoulou and Cimasoni 1996) . Fibroblasts can be distinguished from osteoblasts by expression of a 2.3-kb regulatory unit in the collagen type 1, alpha 1 (Col1α1) promoter that is typically restricted to osteoblasts and osteocytes (Dacquin et al. 2002; Braut et al. 2003) . Moreover, this regulatory element has been used to generate transgenic (Col1α1.IKK-DN) mice that express a dominant negative mutant of IKK in osteoblast-lineage cells (Liu et al. 2004; Chang et al. 2009; Pacios et al. 2015) . We investigated the potential contribution of PDL fibroblasts to diabetes-enhanced periodontitis by examining NF-κB activation and expression of genes that are downstream of NF-κB. Surprisingly, we found that PDL fibroblasts express the 2.3-kb Col1α1 regulatory element and that inflammatory and osteoclastogenic effects of diabetes on PDL fibroblasts can be rescued by lineage-specific NF-κB inhibition in transgenic Col1α1.IKK-DN mice. These studies further establish the phenotype of PDL fibroblasts in vivo and provide evidence regarding how they may contribute to diabetes-enhanced periodontitis.
Material and Methods

Animal Models
Heterozygous 2.3Col1α1-green fluorescent protein (GFP) mice (B6.Cg-Tg[Col1α1*2.3-GFP]1Rowe/J, Stock No. 013134) were purchased from Jackson Laboratory and examined at 3 to 12 wk of age. Mandibles were fixed in 4% paraformaldehyde and decalcified at 4 °C, and CryoJane frozen sections were prepared (Jing et al. 2016) . Fluorescent images were captured with an SP5 Leica confocal microscope. Protocols were approved by the Institutional Animal Care and Use Committee at Texas A&M College of Dentistry.
Periodontal disease studies were approved by the Institutional Animal Care and Use Committee at University of Pennsylvania. Lineage-specific inhibition of IKK was achieved in transgenic mice (Col1α1.IKKDN) as described (Chang et al. 2009 ). Diabetes was induced by intraperitoneal streptozotocin injection (Sigma-Aldrich) for 5 consecutive days (Zhang et al. 2015) . The glucose levels of mice with streptozotocin injection exceeded 220 mg/dL for at least 6 wk (see Appendix Table) . Mice received antibiotics (sulfamethoxazole and trimethoprim) before oral inoculation of Porphyromonas gingivalis and Fusobacterium nucleatum (2 × 10 9 colony-forming units) for 2 wk as previously described (Wu et al. 2016) or vehicle (2% methylcellulose) alone. Mice were euthanized 6 wk after oral inoculation. Mandibles were examined by micro-computed tomography (micro-CT) and then decalcified in 10% EDTA for 4 wk. After paraffin embedding, 4-μm sagittal sections that included the first and second molars were prepared as described (Wu et al. 2016 ).
Micro-CT and Histomorphometric Analysis
The bone between the first and second molars was quantified by micro-CT (μCT35; SCANCO Medical) and in hematoxylin and eosin-stained sections as described (Pacios et al. 2015) . Polymorphonuclear leukocytes (PMNs) were counted in PDL and gingival connective tissue in hematoxylin and eosinstained sections (Kang et al. 2012) . Osteoclasts were identified as large multinucleated cells located on the surface of alveolar bone in tartrate-resistant acid phosphatase-stained sections (Liu et al. 2006) . Images were captured with a Nikon Eclipse 90i microscope, and NIS Elements-AR software (Nikon) was used for analysis.
Detection of NF-κB p65, RANKL, and CXCL2 in PDL and Gingival Connective Tissue by Immunofluorescence
NF-κB, RANKL, and CXC motif chemokine 2 (CXCL2) expressions were assessed by immunofluorescence with antibodies specific for NF-κB p65 (Cell Signaling Technology), RANKL (Santa Cruz), or CXCL2 (Thermo Fisher Scientific). Sections went through antigen retrieval and were then incubated with primary antibody or matched control IgG at 4 °C overnight, followed by incubation with biotinylated secondary antibody (Vector Laboratories), avidin-biotin-peroxidase complex (ABC Reagent; Vector Laboratories), and tyramide signal amplification (PerkinElmer). Immune complexes were localized by incubation with Alexa Fluor 546-conjugated streptavidin (Invitrogen) and mounting medium containing DAPI (Abcam). Fluorescent images were captured and analyzed at 40× magnification with NIS Elements software (Nikon). Nuclear localization of NF-κB p65 was identified by colocalization of NF-κB p65 antibody and DAPI nuclear stain. Fibroblastic cells in the gingiva and PDL were identified by their location and typical fusiform-shaped nucleus in DAPI images, which distinguishes them from bone-lining cells, leukocytes, or endothelial cells. Quantitation was carried out, and the percentage of immunopositive fibroblastic cells in the PDL or gingiva was measured.
NF-κB p65, Phospho-IκBs, and RANKL Expressions in hPDLCs In Vitro
Human PDL cells were generously provided by Dr. Songtao Shi, University of Pennsylvania, and cultured in α-MEM (Mrozik et al. 2017) . Cells were incubated with high glucose (25 mM) and/or tumor necrosis factor alpha (TNF-α) (10 ng/mL) (F) NF-κB p65 nuclear localization was measured in vivo by colocalization of NF-κB p65 (red) and DAPI (blue) nuclear staining and presented as the percentage of fibroblastic cells in the gingiva with NF-κB p65 detected in the nucleus. *P < 0.05 (vs. uninfected normoglycemic group). **P < 0.05 (vs. matched wild-type group). † P < 0.05 (vs. matched normoglycemic group). Col1α1, collagen type 1, alpha 1; GFP, green fluorescent protein; NF-κB, nuclear factor kappa B; PDL, periodontal ligament. Error bars indicate SEM.
for 24 h. Some cells were preincubated with BAY-117082 (Santa Cruz) for 1 h, which was continued after stimulation with high glucose or TNF. mRNA levels of NF-κB p65 and RANKL were determined by real-time quantitative reverse transcription polymerase chain reaction normalized to ribosomal protein L32 with Fast SYBR Green Master Mix (Applied Biosystem). The amplification was monitored by melting curve analysis. Primer sequences were as follows:
NF-κB p65: forward, 5′-GAGACATCCTTCCGCAAACT-3′; reverse, 5′-TCCTTCCTGCCCATAATCA-3′ RANKL: forward, 5′-TGATTCATGTAGGAGAATTAAA CAGG-3′; reverse, 5′-GATGTGCTGTGATCCAACGA-3′ L32: forward, 5′-TGACAACAGGGTTCGTAGAAGAT-3′; reverse, 5′-GTTCTTGGAGGAAACATTGTGAG-3′
Protein levels of phospho-IκBs (RayBiotech) and RANKL (R&D Systems) were assessed by ELISA. NF-κB transcriptional activity was measured with a dual-luciferase reporter assay System (Promega) normalized with a control Renilla luciferase reporter in each assay.
Statistical Analysis
Statistical analysis was performed with SPSS 20.0 software (IBM). In vivo experiments included 7 to 10 mice for each group with a similar distribution of males and females. One specimen was examined from each mouse per study. Each in vitro experiment was repeated at least 3 times with similar results. Analysis of histologic sections was performed by an examiner who evaluated specimens randomly and was blinded to the specimen group. Significance between wild-type and transgenic mice was determined by 2-tailed Student's t test, and differences among multiple groups was established by analysis of variance with Tukey's post hoc test. The significance level was set at P < 0.05.
Results
Localization of GFP in Periodontal Tissue of 2.3Col1α1-GFP Transgenic Mice
Expression of 2.3Col1α1-GFP in the PDL was observed by green fluorescence. Approximately 70% of PDL fibroblasts were GFP positive. No detectable GFP signal was found in epithelium or gingival connective tissue (Fig. 1A) . The expression of this promoter element in the majority of PDL fibroblasts was surprising given previous reports of its restricted expression to osteoblast lineage cells (Dacquin et al. 2002; Braut et al. 2003) .
Diabetes and Oral Infection Induce NF-κB Activation in PDL Fibroblasts
Mice were challenged with oral bacterial inoculation. The expression and nuclear localization of the NF-κB subunit p65 in PDL fibroblasts were examined by immunofluorescence (Fig. 1B-F) . Diabetes alone induced a 59% increase in NF-κB expression and a 90% increase in NF-κB nuclear localization in PDL fibroblasts when compared with normoglycemic animals (P < 0.05; Fig. 1C, D) , indicating increased basal inflammation in PDL fibroblasts caused by diabetes. Infection in † P < 0.05 (vs. matched normoglycemic group). hPDLC, human periodontal ligament cell; IκB, inhibitor of nuclear factor kappa B; NF-κB, nuclear factor kappa B; PDL, periodontal ligament; qRT-PCR, real-time quantitative reverse transcription polymerase chain reaction. Error bars indicate SEM.
wild-type mice (vs. uninfected wild-type mice) induced a 103% increase in PDL fibroblasts that expressed NF-κB and a 229% increase in NF-κB nuclear localization (P < 0.05). When compared with baseline, infected diabetic mice had a 186% increase in NF-κB expression and a 346% increase in NF-κB nuclear localization (P < 0.05). In contrast, the levels of NF-κB were not increased by diabetes or infection in transgenic mice (P > 0.05). Similar increases were noted in gingival fibroblasts in wild-type mice, and there was no difference between transgenic and wild-type mice (P > 0.05; Fig. 1E, F) .
To investigate mechanisms by which diabetes may affect the PDL, human PDL cells (hPDLCs) were incubated in high glucose media (25 mM), media supplemented with TNF-α (10 ng/mL), or both, since each is elevated in high glucose conditions (Pacios et al. 2015) . NF-κB mRNA levels in hPDLCs were enhanced 58% by high glucose, 108% by TNF-α, and 213% by a combination of high glucose and TNF-α (P < 0.05; Fig. 2A ). High glucose and TNF stimulated a 51% increase in NF-κB mRNA levels in hPDLCs when compared with TNF alone (P < 0.05). Increases in NF-κB mRNA levels stimulated by high glucose, TNF-α, or both were completely blocked by the NF-κB inhibitor BAY-117082 (P < 0.05). NF-κB is activated by phosphorylation of IκB. High glucose and TNF-α stimulated an 80% and 130% increase in IκB phosphorylation, respectively, as determined by ELISA (P < 0.05; Fig. 2B) . A luciferase reporter assay demonstrated that high glucose induced a 251% increase in NF-κB transcriptional activity in hPDLCs, while TNF-α stimulated a 439% increase (P < 0.05; Fig. 2C ). High glucose further increased the NF-κB transcriptional activity in hPDLCs by 93% when compared with TNF alone (P < 0.05). The increase in NF-κB transcriptional activity and IκB phosphorylation was largely suppressed when the NF-κB inhibitor BAY-117082 was applied (P < 0.05).
Transgenic Mice Have Reduced RANKL Expression in PDL Fibroblasts, Not Gingival Fibroblasts
Expression of RANKL was measured in PDL and gingival fibroblasts (Fig. 3A,  B) . Diabetes increased by 145% the number of PDL fibroblasts expressing RANKL in uninfected wild-type animals versus normoglycemic controls (P < 0.05; Fig. 3A ). Oral inoculation of bacteria stimulated a 177% increase in RANKL in the PDL fibroblasts as compared with baseline (P < 0.05), which was increased 44% by diabetes (P < 0.05). This number was significantly reduced in transgenic mice (P < 0.05). Diabetes and oral infection also increased RANKL expression in gingival fibroblasts of both wild-type and transgenic mice (Fig. 3B) .
RANKL induction by high glucose in hPDLCs was measured in vitro (Fig. 3C, D) . High glucose stimulated a 74% increase in RANKL mRNA levels; TNF, a 110% increase; and the combination of high glucose and TNF-α, a 215% increase (P < 0.05; Fig. 3C ). ELISA analysis revealed a similar pattern at the protein level (P < 0.05; Fig. 3D ). RANKL expression in hPDLCs induced by high glucose, TNF-α, and high glucose plus TNF-α was blocked by the NF-κB inhibitor BAY-117082 at the mRNA and protein levels (P < 0.05; Fig. 3C, D) .
Inhibition of NF-κB Activation Decreases PMN Numbers in the PDL and Expression of CXCL2
To determine whether diabetes enhances the recruitment of PMNs to the PDL, we examined CXCL2 and PMN numbers in wild-type and transgenic diabetic mice (Fig. 4A-D) . Diabetes stimulated a 211% increase in PMN numbers in wild-type mice, and oral infection induced a 215% increase as compared with normoglycemic, uninfected controls (P < 0.05; Fig. 4A ). In infected wild-type mice, diabetes further stimulated a 74% increase in PMNs in the PDL (P < 0.05). PMN numbers in PDL were significantly lower in matched transgenic mice (P < 0.05). In contrast, diabetes and oral inoculation significantly increased PMN numbers in gingival connective tissue of both wild-type and transgenic groups (Fig. 4B) .
We next examined expression of the neutrophil chemoattractant CXCL2 in PDL fibroblasts by quantitative immunofluorescence (Fig. 4C, D) . CXCL2 in PDL fibroblasts of diabetic mice was 236% higher than corresponding normoglycemic mice (P < 0.05; Fig. 4C ). Oral inoculation increased the expression of CXCL2 by 254% in normoglycemic wild-type mice versus uninfected controls (P < 0.05). Infected diabetic mice had the largest increase, 446% (P < 0.05). The increased CXCL2 expression by PDL fibroblasts was largely blocked in mice lacking NF-κB activation. In gingival fibroblasts, diabetes similarly induced an increase in both uninfected and infected wild-type mice (P < 0.05; Fig. 4D ). Similar increases were observed in gingival fibroblasts of transgenic mice.
Normoglycemic and Diabetic Transgenic Mice with Dominant Negative Inhibition of NF-κB Have Reduced Osteoclast Numbers and Alveolar Bone Loss
The loss of periodontal bone is mediated by osteoclasts. Tartrate-resistant acid phosphatase staining showed that diabetes alone and oral infection alone induced a 225% increase and 307% increase in osteoclasts, respectively (P < 0.05; Fig. 5A, D) , with the highest increase, 548%, in infected diabetic mice (P < 0.05). However, in transgenic mice with diabetes or infection, the osteoclast numbers did not increase in comparison with matched controls (P > 0.05). The effect of oral infection and diabetes on alveolar bone loss was examined by micro-CT and histologic analysis. Diabetes in the absence of infection induced a 20% loss of bone (P < 0.05; Fig. 5B , E) and oral inoculation, a 24% loss (P < 0.05). In diabetic mice, infection caused a 44% loss of bone, which was almost double that of the normoglycemic infected group (P < 0.05). In contrast, no bone loss was observed in transgenic mice (P > 0.05). Similar results were obtained in histologic sections (Fig. 5C, F) .
Discussion
We previously demonstrated that osteoblast lineage cells play an important role in bacteria-induced periodontitis mediated by NF-κB signaling (Pacios et al. 2015 ). In the current study, we surprisingly noted that the PDL fibroblasts strongly expressed the 2.3-kb Col1α1 promotor element. This finding extends our previous work and indicates that PDL fibroblasts, with osteoblast lineage cells, contribute to bone loss as an important source of RANKL in bacteria-induced periodontitis. Most unexpected was GFP staining in the Col 2.3 reporter mice observed in the majority of PDL fibroblasts. In agreement with GFP reporter results was the inhibition of NF-κB, CXCL2, and RANKL expression in a different mouse line that expressed a dominant negative IKK under the control of the same 2.3-kb Col1α1 promoter element. Previous reports indicated that a small percentage of PDL fibroblasts exhibit an osteoblast-like phenotype characterized by the expression of alkaline phosphatase and bone-related proteins (Giannopoulou and Cimasoni 1996) . In addition, a low expression of the 2.3-kb Col1α1 promoter was detected in tendon fibroblasts in Col 2.3 reporter mice (Liu et al. 2004 ). Thus, the data presented here suggest uninfected normoglycemic group). **P < 0.05 (vs. matched wild-type group).
† P < 0.05 (vs. matched normoglycemic group). CXCL2, CXC motif chemokine 2; NF-κB, nuclear factor kappa B; PDL, periodontal ligament; PMN, polymorphonuclear leukocyte. Error bars indicate SEM. Normoglycemic and diabetic transgenic mice with dominant negative inhibition of NF-κB have reduced osteoclast numbers and alveolar bone loss. Diabetes and periodontitis were induced in wild-type and transgenic (Col1α1.IKKDN) mice by streptozotocin injection and oral inoculation. All mice were euthanized 6 wk after completion of oral bacterial inoculation. (A, D) TRAP analysis were carried out to measure the osteoclasts (arrows) identified as multinucleated cells harboring on the bone surface. (B, E) Micro-CT analysis of remaining bone (the different lengths of arrows indicate the difference in alveolar bone height) between the molars in the mandible. (C, F) Bone area was measured in H&E-stained sections between the molars in the mandible. *P < 0.05 (vs. uninfected normoglycemic group). **P < 0.05 (vs. matched wild-type group). † P < 0.05 (vs. matched normoglycemic group). H&E, hematoxylin and eosin; micro-CT, micro-computed tomography; NF-κB, nuclear factor kappa B; TRAP, tartrate-resistant acid phosphatase. Error bars indicate SEM.
